Frequently Asked Questions.

Download our Patient’s Guide to Research e-Book to learn more about clinical trials!

This information comes courtesy of ClinicalTrials.gov website.

WHAT IS A CLINICAL TRIAL?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Visit ClinicalTrials.gov to learn more.

WHO CONDUCTS CLINICAL TRIALS?

Every clinical study is led by a principal investigator, who is often a medical doctor. Clinical studies also have a research team that may include doctors, nurses, social workers, and other health care professionals.

Clinical studies can be sponsored, or funded, by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations, in addition to Federal agencies such as the National Institutes of Health, the U.S. Department of Defense, and the U.S. Department of Veterans Affairs. Doctors, other health care providers, and other individuals can also sponsor clinical research.

WHERE ARE CLINICAL TRIALS CONDUCTED?

Clinical studies can take place in many locations, including hospitals, universities, doctors' offices, and community clinics. The location depends on who is conducting the study.

HOW LONG DO CLINICAL TRIALS LAST?

The length of a clinical study varies, depending on what is being studied. Participants are told how long the study will last before they enroll.

WHO CAN PARTICIPATE IN A CLINICAL TRIAL?

Clinical studies have standards outlining who can participate. These standards are called eligibility criteria and are listed in the protocol. Some research studies seek participants who have the illnesses or conditions that will be studied, other studies are looking for healthy participants, and some studies are limited to a predetermined group of people who are asked by researchers to enroll.

Eligibility. The factors that allow someone to participate in a clinical study are called inclusion criteria, and the factors that disqualify someone from participating are called exclusion criteria. They are based on characteristics such as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions.

HOW ARE PARTICIPANTS PROTECTED?

Informed consent is a process used by researchers to provide potential and enrolled participants with information about a clinical study. This information helps people decide whether they want to enroll or continue to participate in the study. The informed consent process is intended to protect participants and should provide enough information for a person to understand the risks of, potential benefits of, and alternatives to the study. In addition to the informed consent document, the process may involve recruitment materials, verbal instructions, question-and-answer sessions, and activities to measure participant understanding. In general, a person must sign an informed consent document before joining a study to show that he or she was given information on the risks, potential benefits, and alternatives and that he or she understands it. Signing the document and providing consent is not a contract. Participants may withdraw from a study at any time, even if the study is not over. See the Questions to Ask section on this page for questions to ask a health care provider or researcher about participating in a clinical study.

Institutional review boards. Each federally supported or conducted clinical study and each study of a drug, biological product, or medical device regulated by FDA must be reviewed, approved, and monitored by an institutional review board (IRB). An IRB is made up of doctors, researchers, and members of the community. Its role is to make sure that the study is ethical and that the rights and welfare of participants are protected. This includes making sure that research risks are minimized and are reasonable in relation to any potential benefits, among other responsibilities. The IRB also reviews the informed consent document.

In addition to being monitored by an IRB, some clinical studies are also monitored by data monitoring committees (also called data safety and monitoring boards).

Various Federal agencies, including the Office of Human Subjects Research Protection and FDA, have the authority to determine whether sponsors of certain clinical studies are adequately protecting research participants.

WHAT QUESTIONS SHOULD I ASK THE RESEARCH TEAM?

Anyone interested in participating in a clinical study should know as much as possible about the study and feel comfortable asking the research team questions about the study, the related procedures, and any expenses. The following questions may be helpful during such a discussion. Answers to some of these questions are provided in the informed consent document. Many of the questions are specific to clinical trials, but some also apply to observational studies.

  • What is being studied?

  • Why do researchers believe the intervention being tested might be effective? Why might it not be effective? Has it been tested before?

  • What are the possible interventions that I might receive during the trial?

  • How will it be determined which interventions I receive (for example, by chance)?

  • Who will know which intervention I receive during the trial? Will I know? Will members of the research team know?

  • How do the possible risks, side effects, and benefits of this trial compare with those of my current treatment?

  • What will I have to do?

  • What tests and procedures are involved?

  • How often will I have to visit the hospital or clinic?

  • Will hospitalization be required?

  • How long will the study last?

  • Who will pay for my participation?

  • Will I be reimbursed for other expenses?

  • What type of long-term follow-up care is part of this trial?

  • If I benefit from the intervention, will I be allowed to continue receiving it after the trial ends?

  • Will results of the study be provided to me?

  • Who will oversee my medical care while I am participating in the trial?

  • What are my options if I am injured during the study?

HOW CAN I SIGN UP FOR A TRIAL?

Please contact us to determine if you are interested in participating in a clinical trial. A member of our staff will contact you immediately.

WHAT TO EXPECT DURING YOUR SCREENING VISIT

You will come to the clinic for a Screening Visit to determine if you are eligible and willing to participate in the study. You will be asked to undergo procedures that might be different from a regular medical examination. The following procedures may take place during the screening visit and vary by clinical study:

  • Physical exam, including measurement of height, weight and vital signs (temperature, pulse, blood pressure)

  • Medical history discussion

  • Blood draw/samples (to screen general health and to make sure your blood cells and organs are working normally)

  • Alcohol and urine drug screen (urine sample)

  • ECG (electrocardiogram - heart rhythm tracing)

  • Pregnancy test (via urine sample or blood draw depending on specific study protocol)

  • Training of E-Diary device

  • Review of emotional and mental state